
Paul Martens Janeski
Examiner (ID: 4040, Phone: (571)270-1681 , Office: P/3722 )
| Most Active Art Unit | 3722 |
| Art Unit(s) | 3726, 3722 |
| Total Applications | 635 |
| Issued Applications | 463 |
| Pending Applications | 0 |
| Abandoned Applications | 175 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18869848
[patent_doc_number] => 11857628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
[patent_app_type] => utility
[patent_app_number] => 17/533552
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 102544
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533552 | Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation | Nov 22, 2021 | Issued |
Array
(
[id] => 17580196
[patent_doc_number] => 20220137051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/531314
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531314 | IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES | Nov 18, 2021 | Abandoned |
Array
(
[id] => 17441896
[patent_doc_number] => 20220062401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 17/531058
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531058 | VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE | Nov 18, 2021 | Pending |
Array
(
[id] => 17443734
[patent_doc_number] => 20220064239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Cathelicidin-expressing lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 17/529396
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529396 | Cathelicidin-expressing lactic acid bacteria | Nov 17, 2021 | Issued |
Array
(
[id] => 19035601
[patent_doc_number] => 20240085416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN
[patent_app_type] => utility
[patent_app_number] => 18/253755
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253755
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | Nov 15, 2021 | Pending |
Array
(
[id] => 17444084
[patent_doc_number] => 20220064589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => NOVEL LACTOBACILLUS PLANTARUM STRAIN ATG-K2, ATG-K6 OR ATG-K8, AND COMPOSITION FOR PREVENTING OR TREATING VAGINITIS COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/527002
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527002
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527002 | Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising same | Nov 14, 2021 | Issued |
Array
(
[id] => 18842672
[patent_doc_number] => 20230405076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT
[patent_app_type] => utility
[patent_app_number] => 18/035766
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035766
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035766 | COMPOSITION COMPRISING AKKERMANSIA MUCINIPHILA AND GREEN TEA EXTRACT | Nov 2, 2021 | Pending |
Array
(
[id] => 18903079
[patent_doc_number] => 20240018564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => IN SITU TWO-PHASE EXTRACTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/251167
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251167 | IN SITU TWO-PHASE EXTRACTION SYSTEM | Oct 31, 2021 | Pending |
Array
(
[id] => 18215265
[patent_doc_number] => 11590178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep
[patent_app_type] => utility
[patent_app_number] => 17/511544
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2117
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511544 | Application of a bile acid composite bacterial agent in the preparation of feed additives for mutton sheep | Oct 25, 2021 | Issued |
Array
(
[id] => 18844840
[patent_doc_number] => 20230407244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => MICROBIAL GROWTH-STIMULATING PROTEIN AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/250637
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250637
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250637 | MICROBIAL GROWTH-STIMULATING PROTEIN AND METHODS OF USING SAME | Oct 25, 2021 | Abandoned |
Array
(
[id] => 18896500
[patent_doc_number] => 20240011985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => NEUTRALIZED ANTIBODY AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/032657
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032657
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032657 | NEUTRALIZED ANTIBODY AND METHOD OF USE THEREOF | Oct 18, 2021 | Pending |
Array
(
[id] => 18806913
[patent_doc_number] => 20230381246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => GENETICALLY DIVERSE AKKERMANSIA STRAINS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/032781
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032781 | GENETICALLY DIVERSE AKKERMANSIA STRAINS AND METHODS OF USING SAME | Oct 18, 2021 | Pending |
Array
(
[id] => 18784817
[patent_doc_number] => 20230372464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => CHOLERA VACCINE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/027657
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027657
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027657 | CHOLERA VACCINE FORMULATION | Oct 5, 2021 | Pending |
Array
(
[id] => 19815076
[patent_doc_number] => 20250073283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE
[patent_app_type] => utility
[patent_app_number] => 18/248147
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248147 | STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE | Oct 5, 2021 | Pending |
Array
(
[id] => 18972205
[patent_doc_number] => 20240052297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS
[patent_app_type] => utility
[patent_app_number] => 18/029607
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029607
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029607 | MESOPHILIC, METHYLOTROPHIC BACTERIA FOR THE PH-INDEPENDENT PRODUCTION OF BIOCHEMICALS | Sep 29, 2021 | Abandoned |
Array
(
[id] => 19186295
[patent_doc_number] => 20240165208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => Mutant KRAS-Targeting Peptide and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/030222
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030222
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030222 | Mutant KRAS-Targeting Peptide and Use Thereof | Sep 28, 2021 | Pending |
Array
(
[id] => 17670977
[patent_doc_number] => 20220184144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING SEIZURES
[patent_app_type] => utility
[patent_app_number] => 17/486299
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17486299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/486299 | Compositions and methods for inhibiting seizures | Sep 26, 2021 | Issued |
Array
(
[id] => 18816007
[patent_doc_number] => 20230390346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/028378
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028378 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | Sep 23, 2021 | Pending |
Array
(
[id] => 19792195
[patent_doc_number] => 12233118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Multivalent vaccine compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/478584
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 53488
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478584 | Multivalent vaccine compositions and uses thereof | Sep 16, 2021 | Issued |
Array
(
[id] => 19896825
[patent_doc_number] => 12274719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Method for improving walking capacity of elderly subjects
[patent_app_type] => utility
[patent_app_number] => 17/474885
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474885 | Method for improving walking capacity of elderly subjects | Sep 13, 2021 | Issued |